78238-12-7Relevant articles and documents
As neuroprotective agents of pharmaceutical compounds
-
Paragraph 0123; 0124; 0127; 0128, (2019/06/26)
The invention discloses a medicinal compound as a neuroprotective agent. The medicinal compound is a neuronal nitric oxide synthase-postsynaptic density protein 95 (nNOS-PSD95) decoupling agent. The medicinal compound is a benzene ring derivative shown in the general formula (I) or its pharmaceutically acceptable salt. The invention further discloses a preparation method of the medicinal compound and a use of the medicinal compound in prevention and treatment on neuronal damage influence-caused diseases.
Preparation technology of 3-cyano-5-anisole-1-sulfonyl chloride
-
Paragraph 0014-0016; 0031-0033; 0048-0050; 0065-0067, (2018/03/26)
The invention discloses a preparation technology of 3-cyano-5-anisole-1-sulfonyl chloride. The technology comprises the following steps: performing substitution reaction on a raw material which is 3,5-dinitrobenzene to obtain 3-anisyl-5-nitrobenzoic acid;
HETEROCYCLIC DERIVATIVES AND USE THEREOF
-
Page/Page column 73; 74, (2015/01/06)
A heterocyclic derivative represented by formula (I), or a pharmaceutically acceptable salt or a stereoisomer thereof, which has an inhibitory effect on the activation of STAT3 protein, and is useful for the prevention or treatment of diseases associated with the activation of STAT3 protein.